
Q32 Bio Investor Relations Material
Latest events

Corporate Presentation
8 May, 2025

Q1 2025
8 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Q32 Bio Inc
Access all reports
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing biologic therapeutics designed to restore immune balance in patients with autoimmune and inflammatory diseases. The company's product pipeline includes innovative treatments targeting both the innate and adaptive immune systems. The company is based in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Q32 Bio Inc


Q3 2024
Q32 Bio Inc


Corporate Presentation
Q32 Bio Inc
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
QTTB
Country
🇺🇸 United States